Entero Healthcare Solutions Share Price

NSE
1437.8
-14.40 (1.04%)
ENTERO • 23 May, 2025 | 03:29 PM
BUY
The current prices are delayed, login or Open Demat Account for live prices.
Entero Healthcare Solutions Stock Performance
Today’s Low - High
1,421.30
1,459.20
1,421.30
1,459.20
52 Week Low - High
991.10
1,584.25
991.10
1,584.25

Open

1,449.80

Prev. Close

1,452.20

Total Traded Value

7.86 Cr

View details of Market Depth
Entero Healthcare Solutions Fundamental

Market Cap (in crs)

6,209.42

Face Value

10

Turnover (in lacs)

786.29

Key Metrics
Qtr Change %
44.00% Gain from 52W Low
8.5
Dividend yield 1yr %
0

Entero Healthcare Solutions Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Entero Healthcare Solutions Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
1359 Cr
1300.69 Cr
1097.04 Cr
1034.18 Cr
992.63 Cr

Entero Healthcare Solutions Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021
3936.72 Cr
3305.72 Cr
2526.55 Cr
1783.67 Cr

Entero Healthcare Solutions Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
29.45 Cr
26.03 Cr
20.53 Cr
21.18 Cr
6.98 Cr

Entero Healthcare Solutions Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021
39.8 Cr
-11.1 Cr
-29.44 Cr
-15.35 Cr
Entero Healthcare Solutions Result Highlights
  • Entero Healthcare Solutions Ltd reported a 4.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 37.4%.

  • Its expenses for the quarter were up by 3.9% QoQ and 34.6% YoY.

  • The net profit increased 13.1% QoQ and increased 321.9% YoY.

  • The earnings per share (EPS) of Entero Healthcare Solutions Ltd stood at 5.8 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Entero Healthcare Solutions shareholding Pattern

Promoter
52.4%
Foreign Institutions
19.9%
Mutual Funds
6.1%
Domestic Institutions
9.7%
Public
18%
Promoter
52.4%
Foreign Institutions
22.2%
Mutual Funds
5.3%
Domestic Institutions
8.8%
Public
16.6%
Promoter
52.4%
Foreign Institutions
23.8%
Mutual Funds
5.1%
Domestic Institutions
7.8%
Public
16%
Promoter
52.4%
Foreign Institutions
23.3%
Domestic Institutions
2.1%
Public
22.2%
Promoter
52.4%
Foreign Institutions
23.3%
Domestic Institutions
2.3%
Public
22%

Entero Healthcare Solutions Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
1437.8
Current Price
Bullish Moving Averages
12
Bearish Moving Averages
4
5Day EMA
1,436.70
10Day EMA
1,427.50
12Day EMA
1,420.90
20Day EMA
1,392.70
26Day EMA
1,374.20
50Day EMA
1,334.90
100Day EMA
1,319.80
200Day EMA
1,281.20
5Day SMA
1,438.60
10Day SMA
1,445.90
20Day SMA
1,386.00
30Day SMA
1,351.10
50Day SMA
1,279.10
100Day SMA
1,314.30
150Day SMA
1,342.90
200Day SMA
1,340.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
38632 Rs
57357 Rs
Week Rs
27551 Rs
42901 Rs
Month Rs
28461 Rs
48124 Rs
Resistance & Support
1,435.90
Pivot
Resistance
First Resistance
1,450.50
Second Resistance
1,473.80
Third Resistance
1,488.40
Support
First Support
1,412.60
Second support
1,398
Third Support
1,374.70
Relative Strength Index
58.05
Money Flow Index
86.10
MACD
46.70
MACD Signal
47.87
Average True Range
57.57
Average Directional Index
28.58
Rate of Change (21)
5.62
Rate of Change (125)
6.67
Shareholding
Name
Holding Percent
Invesco India Aggressive Hybrid Fund
5.72
Smallcap World Fund, Inc
5.42
Government Of Singapore
4.61
Stichting Depositary Apg Emerging Markets Equity Pool
2.34
Mauryan First
1

Entero Healthcare Solutions Latest News

23 MAY 2025 | Friday

Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

22 MAY 2025 | Thursday

Entero Healthcare Solutions Ltd - 544122 - Update- Submission Of Resignation Letter Of Director

21 MAY 2025 | Wednesday

Entero Healthcare Solutions Ltd - 544122 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31, 2025.

View More

Entero Healthcare Solutions Company background

Founded in: 2018
Managing director: Prabhat Agrawal
Entero Healthcare Solutions Limited was incorporated as Entero Healthcare Solutions Private Limited dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, at New Delhi. Subsequently, the Company was converted into a public limited company and the name of the Company was changed to Entero Healthcare Solutions Limited, and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.The Company was founded in 2018 by Prabhat Agrawal, the Promoter to create an organized, panIndia, technology driven and integrated healthcare products distribution platform that can add value to the entire healthcare ecosystem. The Company is the authorized distributor for most of the top pharmaceutical companies in India. It also has strategic supply relationship with some of the leading corporate hospital chains of the country, The Companys primary line of business is in the distribution of healthcare products to retail pharmacies, hospitals and healthcare clinics in India. The Company acquired 100% shareholding in Novacare Healthcare Solutions Private Limited, making it a wholly owned subsidiary in 2018. In 2022, SS Pharma Traders Private Limited was acquired by the Company, making it a wholly owned subsidiary of the Company. In 2023, Entero R.S. Enterprises Limited and Dhanvanthri Super Speciality Private Limited were acquired as 100% subsidiary of the Company. The Company came up with an IPO of issuing 12,725,244 equity shares of Rs 10 each by raising capital aggregating to Rs 1600 Cr, comprising a fresh issue of 7,955,769 equity shares of Rs 1000 Cr and offer for sale of 4,769,475 equity shares to Rs 600 Cr in February, 2024.The Company operate in the large and highly fragmented Indian healthcare products distribution market and expect to benefit from market consolidation. Subsequent to completion of an acquisition, it deploy growth strategies such as product portfolio expansion, increased customer reach, improved service levels, and technologybased solutions to increase the market share. It is providing the customers through a diverse spectrum of healthcare products, including pharmaceutical products, nutraceuticals, medical devices, surgical consumables, overthecounter medicines and vaccines.
Read More

Entero Healthcare Solutions FAQs

Entero Healthcare Solutions share price is ₹1437.8 in NSE and ₹1440.05 in BSE as on 23/5/2025.

Entero Healthcare Solutions share price in the past 1-year return was 37.27. The Entero Healthcare Solutions share hit a 1-year low of Rs. 991.1 and a 1-year high of Rs. 1584.25.

The market cap of Entero Healthcare Solutions is Rs. 6209.42 Cr. as of 23/5/2025.

The PE ratios of Entero Healthcare Solutions is 73.67 as of 23/5/2025.

The PB ratios of Entero Healthcare Solutions is 3.73 as of 23/5/2025

The Mutual Fund Shareholding in Entero Healthcare Solutions was 6.09% at the end of 23/5/2025.

You can easily buy Entero Healthcare Solutions shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Entero Healthcare Solutions stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -